Filing Details
- Accession Number:
- 0001376339-23-000031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-17 18:26:21
- Reporting Period:
- 2023-05-15
- Accepted Time:
- 2023-05-17 18:26:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1376339 | Mimedx Group Inc. | MDXG | Surgical & Medical Instruments & Apparatus (3841) | 262792552 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1597158 | Benjamin Robert Stein | 1775 West Oak Commons Court Marietta GA 30062 | President, Regenerative Med. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-05-15 | 3,607 | $6.15 | 328,168 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-05-16 | 10,365 | $5.95 | 317,803 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The purchase price indicated is a weighted average purchase price. The corresponding shares were bought in multiple transactions at prices ranging from $6.120 to $6.190, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein.
- The purchase price indicated is a weighted average purchase price. The corresponding shares were bought in multiple transactions at prices ranging from $5.870 to $6.025, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein.